Clinical Trial Update: Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 ) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sintilimab plus chemotherapy versus placebo with chemotherapy in esophageal squamous cell carcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Sintilimab (sintilimab)

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Esophageal Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED